Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Financière de Tubize SA: 2017 half-year financial report

Financière de Tubize SA
Posted on: 27 Jul 17

Press release
27 July 2017  
Embargo till 08:00h CET


Allée de la Recherche 60, 1070 Brussels

Contact: Anne Sophie Pijcke, day-to-day management,

2017 half-year financial report

Regulated information
27 July 2017

The board of directors of Financière de Tubize has issued the 2017 half-year financial report.  This report is available on the website

  • Dividend received from UCB: € 78.3 million
  • Profit for the period when applying the Belgian accounting framework: € 75.3 million
  • Profit for the period when applying the international standard IAS 34: € 154,0 million
  • Participating interest in UCB unchanged at 35.00%
  • Decreasing bank debt from € 241 million at 31 December 2016 to € 189 million at 30 June 2017.
Press release

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Financière de Tubize SA via GlobeNewswire

Last updated on: 28/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.